<article id="post-5" class="post-5 page type-page status-publish hentry"><p class="et_pb_slide_description">
							<h1 class="et_pb_slide_title"><a href="https://thenativeantigencompany.com/products/">Antigens, Antibodies, Immunoassays</a></h1> 
<p>We specialise in the development and manufacture of antigens, antibodies and immunoassays for viral and bacterial pathogens. We produce both native and recombinant antigens using our a range of cell expression systems, and have decades of experience in bulk and scale production.</p>
							
						</p><p class="et_pb_slide_description">
							<h1 class="et_pb_slide_title">Custom and Contract Research Services</h1> 
<p>We can undertake custom projects to manufacture antigens and other proteins, prepare antibodies and develop immunoassays to support your R&amp;D. Our development laboratories are staffed by a team of PhD molecular biologists and development scientists who are able to execute projects as short as a few days, through to long-term programmes of a year or more.</p>
							
						</p><p class="et_pb_blurb_container">
						<h2 class="et_pb_module_header"><a href="https://thenativeantigencompany.com/avoiding-the-immunopathology-pitfalls-of-a-covid-19-vaccine/">Avoiding the Immunopathology Pitfalls of a COVID-19 Vaccine</a></h2>
						 
<p><span>In this blog, we explore the potential challenges in stimulating safe vaccine responses and outline the role that diagnostics will play in guiding their development.</span></p>
					</p><p class="et_pb_button_module_wrapper et_pb_button_0_wrapper et_pb_button_alignment_center et_pb_module ">
				<a class="et_pb_button et_pb_button_0 et_pb_bg_layout_light" href="https://thenativeantigencompany.com/avoiding-the-immunopathology-pitfalls-of-a-covid-19-vaccine/">Read More</a>
			</p><p class="et_pb_blurb_container">
						<h2 class="et_pb_module_header"><a href="https://thenativeantigencompany.com/coronavirus-dashboard/">See our Coronavirus Product Pipeline</a></h2>
						 
<p><span>The Native Antigen Company is developing an extensive range of antigens and antibodies for the human coronaviruses, including SARS-CoV-2 (COVID-19).</span></p>
					</p><p class="et_pb_button_module_wrapper et_pb_button_1_wrapper et_pb_button_alignment_center et_pb_module ">
				<a class="et_pb_button et_pb_button_1 et_pb_bg_layout_light" href="https://thenativeantigencompany.com/coronavirus-dashboard/">Read More</a>
			</p><p class="et_pb_blurb_container">
						<h2 class="et_pb_module_header"><a href="https://thenativeantigencompany.com/novel-coronavirus-antigens-now-available/">SARS-CoV-2 S1 and S2 Antigens Now Available</a></h2>
						 
<p><span>The Native Antigen Company is now offering recombinant S1 and S2 glycoproteins for SARS-CoV-2 (COVID-19) in response to urgent demand.</span></p>
 
					</p><p class="et_pb_button_module_wrapper et_pb_button_2_wrapper et_pb_button_alignment_center et_pb_module ">
				<a class="et_pb_button et_pb_button_2 et_pb_bg_layout_light" href="https://thenativeantigencompany.com/novel-coronavirus-antigens-now-available/">Read More</a>
			</p><p class="et_pb_text_inner"><h2><span>About The Native Antigen Company</span></h2>
<p><span>&#160;The Native Antigen Company specialises in the development and manufacture of native and recombinant viral and bacterial antigens, antibodies and immunoassays, as well as&#160;bespoke product development and custom manufacturing. The&#160;company has decades of experience in producing high-quality proteins with its proprietary mammalian cell expression system to ensure correct glycosylation and proper folding. The Native Antigen Company&#8217;s&#160;high-quality reagents are&#160;widely adopted by leading pharmaceutical, in vitro diagnostic assay manufacturers, and academic groups in cutting-edge vaccine research and serology, where correct folding and glycosylation are vital.</span></p></p><p class="et_pb_slide_description">
															<h2 class="et_pb_slide_title"><a href="https://thenativeantigencompany.com/a-qa-with-david-flavell-of-leukaemia-busters/">A Q&amp;A with David Flavell of Leukaemia Busters</a></h2>
								
									<p class="post-meta">by <span class="author vcard"><a href="https://thenativeantigencompany.com/author/jshore/" title="Posts by James Shore" rel="author">James Shore</a></span> | <span class="published">20th May 2020</span> | <a href="https://thenativeantigencompany.com/category/cancer/" rel="category tag">Cancer</a>, <a href="https://thenativeantigencompany.com/category/covid-19/" rel="category tag">COVID-19</a>, <a href="https://thenativeantigencompany.com/category/disease-insight/" rel="category tag">Disease insight</a>, <a href="https://thenativeantigencompany.com/category/research/" rel="category tag">Research</a>, <a href="https://thenativeantigencompany.com/category/toxins/" rel="category tag">Toxins</a> | 0 Comments</p><p>In this blog, we speak with Dr. David Flavell about his scientific career, the legacy of Leukaemia Busters, and the recent impact that COVID-19 has had on his research.Tell me about your scientific background David. I was born in a seaside town called Southport in...</p>								
														<p class="et_pb_button_wrapper"><a class="et_pb_button et_pb_more_button" href="https://thenativeantigencompany.com/a-qa-with-david-flavell-of-leukaemia-busters/">Read More</a></p>						</p><p class="et_pb_slide_description">
															<h2 class="et_pb_slide_title"><a href="https://thenativeantigencompany.com/avoiding-the-immunopathology-pitfalls-of-a-covid-19-vaccine/">Avoiding the Immunopathology Pitfalls of a COVID-19 Vaccine</a></h2>
								
									<p class="post-meta">by <span class="author vcard"><a href="https://thenativeantigencompany.com/author/jshore/" title="Posts by James Shore" rel="author">James Shore</a></span> | <span class="published">4th May 2020</span> | <a href="https://thenativeantigencompany.com/category/coronaviruses/" rel="category tag">Coronaviruses</a>, <a href="https://thenativeantigencompany.com/category/covid-19/" rel="category tag">COVID-19</a>, <a href="https://thenativeantigencompany.com/category/disease-insight/" rel="category tag">Disease insight</a>, <a href="https://thenativeantigencompany.com/category/immunoassays/" rel="category tag">Immunoassays</a>, <a href="https://thenativeantigencompany.com/category/vaccines/" rel="category tag">Vaccines</a> | 0 Comments</p><p>In the second of a three-part series on COVID-19 vaccines, we explore the potential challenges in stimulating safe vaccine responses and outline the role that diagnostics will play in guiding their development.Rogue Responses Antibodies play a crucial role in...</p>								
														<p class="et_pb_button_wrapper"><a class="et_pb_button et_pb_more_button" href="https://thenativeantigencompany.com/avoiding-the-immunopathology-pitfalls-of-a-covid-19-vaccine/">Read More</a></p>						</p><p class="et_pb_slide_description">
															<h2 class="et_pb_slide_title"><a href="https://thenativeantigencompany.com/designing-for-differentiation-why-we-need-highly-specific-diagnostics-for-a-covid-19-vaccine/">Designing for Differentiation: Why We Need Highly Specific Diagnostics for a COVID-19 Vaccine</a></h2>
								
									<p class="post-meta">by <span class="author vcard"><a href="https://thenativeantigencompany.com/author/jshore/" title="Posts by James Shore" rel="author">James Shore</a></span> | <span class="published">15th April 2020</span> | <a href="https://thenativeantigencompany.com/category/coronaviruses/" rel="category tag">Coronaviruses</a>, <a href="https://thenativeantigencompany.com/category/covid-19/" rel="category tag">COVID-19</a>, <a href="https://thenativeantigencompany.com/category/immunoassays/" rel="category tag">Immunoassays</a>, <a href="https://thenativeantigencompany.com/category/research/" rel="category tag">Research</a>, <a href="https://thenativeantigencompany.com/category/vaccines/" rel="category tag">Vaccines</a> | 0 Comments</p><p>Assessment of vaccine-induced immune responses in clinical trials will require highly specific diagnostic assays to ensure safety. This blog was originally published on Clinical Lab Manager.The Vaccine Race Vaccines are the most effective means of preventing...</p>								
														<p class="et_pb_button_wrapper"><a class="et_pb_button et_pb_more_button" href="https://thenativeantigencompany.com/designing-for-differentiation-why-we-need-highly-specific-diagnostics-for-a-covid-19-vaccine/">Read More</a></p>						</p><p class="et_pb_slide_description">
															<h2 class="et_pb_slide_title"><a href="https://thenativeantigencompany.com/an-early-look-at-vaccines-for-covid-19/">An Early Look at Vaccines for COVID-19</a></h2>
								
									<p class="post-meta">by <span class="author vcard"><a href="https://thenativeantigencompany.com/author/jshore/" title="Posts by James Shore" rel="author">James Shore</a></span> | <span class="published">14th April 2020</span> | <a href="https://thenativeantigencompany.com/category/coronaviruses/" rel="category tag">Coronaviruses</a>, <a href="https://thenativeantigencompany.com/category/covid-19/" rel="category tag">COVID-19</a>, <a href="https://thenativeantigencompany.com/category/vaccines/" rel="category tag">Vaccines</a> | 0 Comments</p><p>In the first of a three-part series on the design, immunology and manufacture of COVID-19 vaccines, we take an early look at the major technologies under development and weigh-up the challenges these vaccines will face in reaching late-phase clinical trials.Why We...</p>								
														<p class="et_pb_button_wrapper"><a class="et_pb_button et_pb_more_button" href="https://thenativeantigencompany.com/an-early-look-at-vaccines-for-covid-19/">Read More</a></p>						</p><p class="et_pb_slide_description">
															<h2 class="et_pb_slide_title"><a href="https://thenativeantigencompany.com/the-bumpy-road-to-a-cytomegalovirus-vaccine/">The Bumpy Road to a Cytomegalovirus Vaccine</a></h2>
								
									<p class="post-meta">by <span class="author vcard"><a href="https://thenativeantigencompany.com/author/jshore/" title="Posts by James Shore" rel="author">James Shore</a></span> | <span class="published">10th April 2020</span> | <a href="https://thenativeantigencompany.com/category/cmv/" rel="category tag">CMV</a>, <a href="https://thenativeantigencompany.com/category/disease-insight/" rel="category tag">Disease insight</a>, <a href="https://thenativeantigencompany.com/category/vaccines/" rel="category tag">Vaccines</a> | 0 Comments</p><p>The development of a cytomegalovirus vaccine has been 50 years in the making. Are there any technologies in the pipeline that could prompt a breakthrough?&#160;This article was originally posted online at The Medicine Maker, a Texere publication.To say that...</p>								
														<p class="et_pb_button_wrapper"><a class="et_pb_button et_pb_more_button" href="https://thenativeantigencompany.com/the-bumpy-road-to-a-cytomegalovirus-vaccine/">Read More</a></p>						</p><h3 class="et_pb_contact_main_title">Get in Touch</h3><p class="et_pb_contact">
					
						<p class="et_pb_contact_field et_pb_contact_field_0 et_pb_contact_field_half">
				
				
				Name
				
			</p><p class="et_pb_contact_field et_pb_contact_field_1 et_pb_contact_field_half et_pb_contact_field_last">
				
				
				Email Address
				
			</p><p class="et_pb_contact_field et_pb_contact_field_2 et_pb_contact_field_last">
				
				
				Message
				
			</p><p class="et_pb_contact_field et_pb_contact_field_3 et_pb_contact_field_last">
				
				
				We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these
				<span class="et_pb_contact_field_options_wrapper">
						<span class="et_pb_contact_field_options_title">We sometimes send exclusive information and offers to our customers - please let us know if you are happy to receive these</span>
						<span class="et_pb_contact_field_options_list"><span class="et_pb_contact_field_radio">
								
								Yes please, keep me up to date
							</span><span class="et_pb_contact_field_radio">
								
								No thank you
							</span></span>
					</span>
			</p>
						<p class="et_pb_contact_field et_pb_contact_field_4 et_pb_contact_field_half">
							Number
							
						</p>
						
						
							
			
				<p class="clearfix">
					<span class="et_pb_contact_captcha_question">9 + 6</span> = 
				</p>
			  
							
						
						
					
				</p><p class="et_pb_text_inner"><h3>Live Customer Feedback</h3></p><p id="chart_value"><span>91.32%</span></p><p>on <a href="https://www.customerthermometer.com">customerthermometer.com</a></p></article>